Summary
Cigna Group reported solid financial results for the second quarter and first half of 2020, demonstrating resilience amidst the COVID-19 pandemic. Total revenues saw a modest increase, driven by growth in Pharmacy and Premiums, though partially offset by a decline in Fees and Other Revenues. Net income and Shareholders' net income showed significant year-over-year improvements, largely attributable to strong performance in the Integrated Medical and Health Services segments. This improvement was fueled by decreased medical utilization due to deferred care, which more than offset increased COVID-19 related costs and premium relief programs. The company also made strategic moves, including progressing the sale of its U.S. Group Disability and Life insurance business and actively managing its capital structure through debt repayment and share repurchases. Cigna highlighted its proactive approach to supporting customers, providers, and communities during the pandemic, underscoring its commitment to affordability, simplicity, and predictability in healthcare delivery. The company maintained a strong liquidity position, with substantial cash and committed credit facilities available.
Financial Highlights
47 data pointsKey Highlights
- 1Total revenues for the second quarter of 2020 were $39.265 billion, a slight increase from $38.819 billion in the prior year period, driven by growth in Pharmacy and Premiums.
- 2Shareholders' net income increased by 25% to $1.754 billion for the second quarter of 2020, compared to $1.408 billion in the prior year, with diluted EPS at $4.73.
- 3The Integrated Medical segment saw a significant improvement in its medical care ratio (MCR) to 70.5% from 81.6% due to deferred medical utilization caused by COVID-19, leading to higher pre-tax adjusted income.
- 4The company is progressing with the sale of its U.S. Group Disability and Life insurance business, expected to close in the third quarter of 2020, which is anticipated to yield approximately $5.3 billion in net after-tax proceeds.
- 5Cigna repurchased $1.3 billion of common stock in the first six months of 2020 and has significant share repurchase authority remaining.
- 6The company maintained a strong liquidity position, with $7.6 billion in cash and short-term investments and $4.25 billion of undrawn committed capacity under revolving credit agreements as of June 30, 2020.
- 7COVID-19 impacted medical utilization, leading to lower benefit expenses but also prompting premium relief programs, a net positive for earnings in the quarter due to utilization declines significantly outweighing costs.